CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt

Nature Communications

Volumn 3, Issue , 2012, Pages

  Lim, Jae Hyang ^a,b   Jono, Hirofumi ^b,c   Komatsu, Kensei ^a,b   Woo, Chang Hoon ^d   Lee, Jiyun ^a,b   Miyata, Masanori ^a,b   Matsuno, Takashi ^a,b   Xu, Xiangbin ^b   Huang, Yuxian ^e   Zhang, Wenhong ^e   Park, Soo Hyun ^f   Kim, Yu Il ^g   Choi, Yoo Duk ^f   Shen, Huahao ^h   Heo, Kyung Sun ^b   Xu, Haodong ^b   Bourne, Patricia ^b   Koga, Tomoaki ^b   Xu, Haidong ^a,b   Yan, Chen ^b   Wang, Binghe ^a   Chen, Lin Feng ⁱ   Feng, Xin Hua ^j,k   Li, Jian Dong ^a,b   more..

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c KUMAMOTO UNIVERSITY   (Japan)

^d Yeungnam University College of Medicine   (South Korea)

^e FUDAN UNIVERSITY   (China)

^f Chonnam National University   (South Korea)

^g Internal Medicine   (South Korea)

^h ZHEJIANG UNIVERSITY   (China)

ⁱ UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^j ZHEJIANG UNIVERSITY   (China)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE CYLD; ENZYME; HEAT SHOCK COGNATE PROTEIN 70; PROTEIN KINASE B; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD3 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CYLD PROTEIN, HUMAN; CYLD PROTEIN, MOUSE; CYSTEINE PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG FIBROSIS; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; C57BL MOUSE; CELL LINE; DOWN REGULATION; ENZYMOLOGY; GENETICS; LUNG; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; STREPTOCOCCUS PNEUMONIAE;

MUS; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; DOWN-REGULATION; HUMANS; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMOCOCCAL INFECTIONS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR SUPPRESSOR PROTEINS; UBIQUITINATION;

EID: 84860284249     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1776     Document Type: Article

References (46)

1. Lim, J. H. et al. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27, 349-360 (2007). (Pubitemid 47284927)
2. Wallace, W. A., Fitch, P. M., Simpson, A. J. & Howie, S. E. Inflammation-associated remodelling and fibrosis in the lung - a process and an end point. Int. J. Exp. Pathol. 88, 103-110 (2007). (Pubitemid 46570076)
3. Zhang, K. & Phan, S. H. Cytokines and pulmonary fibrosis. Biol. Signal. 5, 232-239 (1996). (Pubitemid 26325353)
4. Tager, A. M. et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat. Med. 14, 45-54 (2008).
5. Rhodes, G. C., Lykke, A. W., Tapsall, J. W. & Smith, L. W. Abnormal alveolar epithelial repair associated with failure of resolution in experimental streptococcal pneumonia. J. Pathol. 159, 245-253 (1989). (Pubitemid 19278811)
6. Ley, K. & Zarbock, A. From lung injury to fibrosis. Nat. Med. 14, 20-21 (2008).
7. Ghosh, A. K. & Vaughan, D. E. PAI-1 in Tissue Fibrosis. J. Cell. Physiol. 227, 493-507 (2012).
8. Loskutoff, D. J. & Quigley, J. P. PAI-1, fibrosis, and the elusive provisional fibrin matrix. J. Clin. Invest. 106, 1441-1443 (2000). (Pubitemid 32038581)
9. Shetty, S., Padijnayayveetil, J., Tucker, T., Stankowska, D. & Idell, S. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L967-975 (2008).
10. Bonniaud, P. et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J. Immunol. 173, 2099-2108 (2004). (Pubitemid 38971648)
11. Izumi, N. et al. BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L120-126 (2006).
12. Hattori, N. et al. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J. Clin. Invest. 106, 1341-1350 (2000).
13. Bonniaud, P. et al. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J. Immunol. 175, 5390-5395 (2005). (Pubitemid 41456425)
14. Lasky, J. A. & Brody, A. R. Interstitial fibrosis and growth factors. Environ. Health Perspect. 108(Suppl 4), 751-762 (2000).
15. Beisswenger, C., Coyne, C. B., Shchepetov, M. & Weiser, J. N. Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J. Biol. Chem. 282, 28700-28708 (2007). (Pubitemid 47606066)
16. Bartram, U. & Speer, C. P. The role of transforming growth factor beta in lung development and disease. Chest 125, 754-765 (2004). (Pubitemid 38223659)
17. Yu, H. et al. Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. Faseb J. 22, 1778-1789 (2008). (Pubitemid 351811455)
18. Feng, X. H. & Derynck, R. Specificity and versatility in tgf-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693 (2005). (Pubitemid 41740650)
19. Massague, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783-2810 (2005). (Pubitemid 41739965)
20. ten Dijke, P. & Hill, C. S. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29, 265-273 (2004).
21. Laiho, M., Weis, M. B. & Massague, J. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265, 18518-18524 (1990).
22. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. & Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797-801 (2003). (Pubitemid 37021711)
23. Massoumi, R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem. Sci. 35, 392-399.
24. Yoshida, H., Jono, H., Kai, H. & Li, J. D. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J. Biol. Chem. 280, 41111-41121 (2005). (Pubitemid 41780606)
25. Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. & Fassler, R. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 125, 665-677 (2006).
26. Sun, S. C. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ. 17, 25-34.
27. Reiley, W. W. et al. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat. Immunol. 7, 411-417 (2006).
28. Trompouki, E. et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796 (2003). (Pubitemid 37021710)
29. Kovalenko, A. et al. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424, 801-805 (2003). (Pubitemid 37021712)
30. Inoue, Y. & Imamura, T. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci. 99, 2107-2112 (2008).
31. Xin, H. et al. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J. Biol. Chem. 280, 20842-20850 (2005). (Pubitemid 40776789)
32. Li, L. et al. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol. Cell. Biol. 24, 856-864 2004). (Pubitemid 38057935)
33. Guo, X. et al. Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev. 22, 106-120 (2008).
34. Woo, C. H. et al. Novel role of C terminus of Hsc70-interacting protein (CHIP) ubiquitin ligase on inhibiting cardiac apoptosis and dysfunction via regulating ERK5-mediated degradation of inducible cAMP early repressor. Faseb J. 24, 4917-4928.
35. Sutherland, C., Leighton, I. A. & Cohen, P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296 (Part 1), 15-19 (1993). (Pubitemid 23344723)
36. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995). (Pubitemid 26004411)
37. Yuan, T. L. & Cantley, L. C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510 (2008).
38. Mahmoudi, S. et al. WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol. 8, e1000521.
39. Coste, I. et al. Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. J. Clin. Invest. 120, 3663-3667.
40. Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134-1138 (2009).
41. Trompouki, E. et al. Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation. Neoplasia 11, 469-476 (2009).
42. Jono, H. et al. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1- dependent inhibition of p38 MAPK. J. Biol. Chem. 278, 27811-27819 (2003). (Pubitemid 36899973)
43. Jono, H. et al. Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J. Biol. Chem. 277, 45547-45557 (2002). (Pubitemid 36159165)
44. Elia, U. & Flescher, E. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells. Neoplasia 10, 1303-1313 (2008).
45. Hu, Y. et al. 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J. Med. Chem. 43, 3045-3051 (2000). (Pubitemid 30626762)
46. Mikami, F. et al. The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK. J. Biol. Chem. 281, 22397-22408 (2006). (Pubitemid 44181942)